Carol P. Sanders
Carol P. Sanders's purchase track record
How the stock did after each of Carol P. Sanders's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/30/2024 | FBIZ | $6K | +11.7% | +10.9% | -4.2% |
| 7/30/2024 | FBIZ | $6K | -3.1% | +6.9% | +11.6% |
| 5/1/2024 | FBIZ | $6K | +33.4% | +27.9% | +15.8% |
| 1/30/2024 | FBIZ | $6K | -13.7% | +20.8% | +10.4% |
| 10/31/2023 | FBIZ | $6K | +26.6% | +9.3% | +20.1% |
| 8/1/2023 | FBIZ | $6K | -8.8% | +15.4% | +7.6% |
| 8/4/2022 | FBIZ | $6K | +14.0% | +10.1% | +0.7% |
| 5/5/2022 | FBIZ | $6K | -6.0% | +7.1% | -10.3% |
| 3/9/2022 | FBIZ | $6K | +6.7% | +5.3% | -7.0% |
| 11/2/2021 | FBIZ | $8K | +11.7% | +17.0% | -9.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Raymond James Upgrades First Business Financial Services to Outperform. Raymond James upgraded First Business Financial Services to Outperform, setting a $75 price target. The target sits near the upper end of the 52‑week range and aligns with the current analyst consensus of $79.20. The stock’s RSI of 52.6 suggests it is neither overbought nor oversold, and it remains above its $56.82 support level.
Transaction History
| RNR | ▼ Sell | Open Market | 1,479 | $440K | 5/18/2026 | View on chart |
| RNR | ▲ Buy | Grant | 578 | $0 | 3/1/2026 | View on chart |
| RNR | ▲ Buy | Grant | 694 | $0 | 3/1/2025 | View on chart |
| FBIZ | ▼ Sell | Open Market | 670 | $33K | 12/13/2024 | View on chart |
| FBIZ | ▼ Sell | Open Market | 8,211 | $401K | 12/13/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 102 | $5K | 10/30/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 32 | $1K | 10/30/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 129 | $6K | 7/30/2024 | View on chart |
| FBIZ | ▲ Buy | Grant | 655 | $0 | 5/16/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 100 | $3K | 5/1/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 75 | $3K | 5/1/2024 | View on chart |
| RNR | ▲ Buy | Grant | 738 | $0 | 3/1/2024 | View on chart |
| RNR | ▼ Sell | Open Market | 55 | $13K | 2/12/2024 | View on chart |
| RNR | ▼ Sell | Open Market | 825 | $188K | 2/12/2024 | View on chart |
| RNR | ▼ Sell | Gift | 132 | $0 | 2/12/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 115 | $4K | 1/30/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 6 | $231 | 1/30/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 35 | $1K | 1/30/2024 | View on chart |
| FBIZ | ▲ Buy | Open Market | 1 | $31 | 10/31/2023 | View on chart |
| FBIZ | ▲ Buy | Open Market | 192 | $6K | 10/31/2023 | View on chart |
| FBIZ | ▲ Buy | Open Market | 177 | $6K | 8/1/2023 | View on chart |
| FBIZ | ▲ Buy | Grant | 830 | $0 | 5/16/2023 | View on chart |
| FBIZ | ▲ Buy | Grant | 218 | $6K | 5/2/2023 | View on chart |
| RNR | ▲ Buy | Grant | 759 | $0 | 3/1/2023 | View on chart |
| RNR | ▼ Sell | Open Market | 1,515 | $320K | 2/16/2023 | View on chart |
| RNR | ▼ Sell | Gift | 145 | $0 | 2/16/2023 | View on chart |
| FBIZ | ▲ Buy | Grant | 172 | $6K | 1/31/2023 | View on chart |
| FBIZ | ▲ Buy | Grant | 157 | $6K | 11/1/2022 | View on chart |
| FBIZ | ▲ Buy | Grant | 375 | $0 | 8/16/2022 | View on chart |
| FBIZ | ▲ Buy | Open Market | 181 | $6K | 8/4/2022 | View on chart |
| FBIZ | ▲ Buy | Grant | 290 | $0 | 5/16/2022 | View on chart |
| FBIZ | ▲ Buy | Open Market | 171 | $6K | 5/5/2022 | View on chart |
| FBIZ | ▲ Buy | Open Market | 190 | $6K | 3/9/2022 | View on chart |
| RNR | ▲ Buy | Grant | 1,065 | $0 | 3/1/2022 | View on chart |
| FBIZ | ▲ Buy | Open Market | 260 | $8K | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
RenaissanceRe Q2 2026 Earnings Call Highlights Discounted Valuation
During the Q2 2026 earnings call, RenaissanceRe reiterated its diversified reinsurance strategy and maintained a cautious outlook. Analysts noted the stock trades at a discount to peers, with a 142% run and a P/E of 5.2, suggesting potential undervaluation. The company’s dividend yield of 0.69% and analyst target of $346.40 contrast with its current price near the 52‑week low of $231.17. RSI sits at 45.5 and the support level at $292.90 adds context to its valuation debate.
RenaissanceRe Q2 2026 Earnings Call Highlights Discounted Valuation. During the Q2 2026 earnings call, RenaissanceRe reiterated its diversified reinsurance strategy and maintained a cautious outlook. Analysts noted the stock trades at a discount to peers, with a 142% run and a P/E of 5.2, suggesting potential undervaluation. The company’s dividend yield of 0.69% and analyst target of $346.40 contrast with its current price near the 52‑week low of $231.17. RSI sits at 45.5 and the support level at $292.90 adds context to its valuation debate.